The association of BRAF mutant genes with increased autophagic activity was exploited towards establishing novel as well as efficient anti-cancer treatment protocols, which involve either inhibitors of autophagy as a single agent treatment or their rational combination with BRAF600E targeting drugs. Here, BRAF is linked to cancer.